GRIP 2022: Reuniting All Together

1234567891011121314151617181920
Across
  1. 3. Dr. ____ has been recognized with distinctions including MIT Technology Review’s “Top 100 Young Innovators” and the Presidential Early Career Award for Scientists and Engineers.
  2. 7. Four-stranded DNA.
  3. 8. The newest CSAP Faculty at the Faculty of Pharmacy: Dr. ____.
  4. 9. Overuse of antibiotic could lead to ____ resistance.
  5. 13. The study of the use of and the effects of drugs in large populations.
  6. 16. The name of the new Pharmacy at Leslie Dan Faculty of Pharmacy: ____ Pharmacy.
  7. 17. A membrane protein involved in the movement of molecules across a biological membrane.
  8. 18. ____ of Pharmaceuticals and Specialties is a reference book released annually by the Canadian Pharmacists Association that contains drug monographs that help healthcare professionals prescribe and use drugs safely and appropriately.
  9. 20. The inaugural Associate Vice-President and Vice-Provost Strategic Initiatives: Dr. ____.
Down
  1. 1. A type of adverse drug reaction that does not occur in most patients and does not involve the intended therapeutic effect of the drug.
  2. 2. Mr. Grima, MSc., is the Senior Vice President and General Manager at ____.
  3. 3. A term commonly used to describe the use of five or more medications daily by an individual.
  4. 4. A drug delivery system used for targeted delivery and controlled release of therapeutic agents.
  5. 5. The brand name of the only approved vaccine for malaria.
  6. 6. The newest BMS Faculty at the Faculty of Pharmacy: Dr. ____.
  7. 10. A cutting tool used for microscopy sample preparation, generating extremely thin slices.
  8. 11. A system for the delivery of poorly soluble drugs: ____solid dispersions.
  9. 12. The Latin motto of The Faculty of Pharmacy's Arms and Badge: Trutina Penso ____.
  10. 14. The Canada Research Chair in Synthetic Biology and Human Health: Dr. ____.
  11. 15. deficiency in this DNA repair protein increases reactive oxygen species (ROS) formation and ROS-mediated DNA damage in the fetus.
  12. 19. Dr. Rajakulendran is the Director of ____ Operations at Edesa Biotech, Inc.